New! Search for patents from more than 100 countries including Australia, Brazil, Sweden and more

WO2004076403A1 - Sumatriptan crystalline forms, pharmaceutical compositions and methods - Google Patents

Sumatriptan crystalline forms, pharmaceutical compositions and methods Download PDF

Info

Publication number
WO2004076403A1
WO2004076403A1 PCT/US2004/005560 US2004005560W WO2004076403A1 WO 2004076403 A1 WO2004076403 A1 WO 2004076403A1 US 2004005560 W US2004005560 W US 2004005560W WO 2004076403 A1 WO2004076403 A1 WO 2004076403A1
Authority
WO
WIPO (PCT)
Prior art keywords
form
sumatriptan
degrees
ray diffraction
diffraction pattern
Prior art date
Application number
PCT/US2004/005560
Other languages
English (en)
French (fr)
Inventor
Sherry L. Morissette
Örn ALMARSSON
Michael Read
Original Assignee
Transform Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US44955403P priority Critical
Priority to US60/449,554 priority
Application filed by Transform Pharmaceuticals, Inc. filed Critical Transform Pharmaceuticals, Inc.
Publication of WO2004076403A1 publication Critical patent/WO2004076403A1/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING, DISPERSING
    • B01F3/00Mixing, e.g. dispersing, emulsifying, according to the phases to be mixed
    • B01F3/18Mixing, e.g. dispersing, emulsifying, according to the phases to be mixed solid with solids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING, DISPERSING
    • B01F11/00Mixers with shaking, oscillating, or vibrating mechanisms
    • B01F11/0065Mixers with shaking, oscillating, or vibrating mechanisms the material being contained in a flexible bag submitted to periodical deformation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING, DISPERSING
    • B01F13/00Other mixers; Mixing plant, including combinations of mixers, e.g. of dissimilar mixers
    • B01F13/02Mixers with gas or liquid agitation, e.g. with air supply tubes
    • B01F13/0272Mixers with gas or liquid agitation, e.g. with air supply tubes by blowing gas on the material from above
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING, DISPERSING
    • B01F7/00Mixers with rotary stirring devices in fixed receptacles, i.e. movement of the receptacle not being meant to effect the mixing; Kneaders
    • B01F7/16Mixers with rotary stirring devices in fixed receptacles, i.e. movement of the receptacle not being meant to effect the mixing; Kneaders with stirrers rotating about a substantially vertical axis
    • B01F7/18Mixers with rotary stirring devices in fixed receptacles, i.e. movement of the receptacle not being meant to effect the mixing; Kneaders with stirrers rotating about a substantially vertical axis with paddles or arms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/02Burettes; Pipettes
    • B01L3/021Pipettes, i.e. with only one conduit for withdrawing and redistributing liquids
    • B01L3/0217Pipettes, i.e. with only one conduit for withdrawing and redistributing liquids of the plunger pump type
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01GWEIGHING
    • G01G19/00Weighing apparatus or methods adapted for special purposes not provided for in the preceding groups
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/286Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING, DISPERSING
    • B01F13/00Other mixers; Mixing plant, including combinations of mixers, e.g. of dissimilar mixers
    • B01F13/0059Micromixers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING, DISPERSING
    • B01F7/00Mixers with rotary stirring devices in fixed receptacles, i.e. movement of the receptacle not being meant to effect the mixing; Kneaders
    • B01F7/00008Stirrers, i.e. rotary stirring devices
    • B01F7/00233Configuration of the rotating mixing element
    • B01F7/0025Configuration of the rotating mixing element with arms, paddles, vanes or blades
    • B01F7/00258Configuration of the rotating mixing element with arms, paddles, vanes or blades pin shaped
PCT/US2004/005560 2003-02-24 2004-02-23 Sumatriptan crystalline forms, pharmaceutical compositions and methods WO2004076403A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US44955403P true 2003-02-24 2003-02-24
US60/449,554 2003-02-24

Publications (1)

Publication Number Publication Date
WO2004076403A1 true WO2004076403A1 (en) 2004-09-10

Family

ID=32927536

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/005560 WO2004076403A1 (en) 2003-02-24 2004-02-23 Sumatriptan crystalline forms, pharmaceutical compositions and methods

Country Status (1)

Country Link
WO (1) WO2004076403A1 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009037718A2 (en) * 2007-09-17 2009-03-26 Matrix Laboratories Limited Process for preparing 3-(2-(dimethylamino)ethyl)-n- methyl-1h-indole-5-methanesulfonamide and product thereof
WO2009128089A2 (en) * 2008-02-11 2009-10-22 Matrix Laboratories Limited Novel solvate form of sumatriptan succinate and process for preparing sumatriptan salt employing the same

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2162522A (en) * 1984-08-01 1986-02-05 Glaxo Group Ltd An indole derivative
US4816470A (en) * 1982-06-07 1989-03-28 Glaxo Group Limited Heterocyclic compounds
US5037845A (en) * 1984-08-01 1991-08-06 Glaxo Group Limited Indole derivative
EP0490689A1 (en) * 1990-12-12 1992-06-17 Glaxo Group Limited 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide sulphate (2:1)
EP0503440A1 (en) * 1991-03-08 1992-09-16 Glaxo Group Limited Compositions containing sumatriptan
US6255502B1 (en) * 1996-07-11 2001-07-03 Farmarc Nederland B.V. Pharmaceutical composition containing acid addition salt of basic drug
US20030181432A1 (en) * 2000-06-29 2003-09-25 Lancaster Robert William Process for preparing and harvesting crystalline particles
WO2003105836A1 (en) * 2002-06-13 2003-12-24 Dr. Reddy's Laboratories Limited 3-'2-(Dimethylamino) ethyl!-N-methyl-1H-indole-5-methanesulfonamide and the Succinate Thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816470A (en) * 1982-06-07 1989-03-28 Glaxo Group Limited Heterocyclic compounds
GB2162522A (en) * 1984-08-01 1986-02-05 Glaxo Group Ltd An indole derivative
US5037845A (en) * 1984-08-01 1991-08-06 Glaxo Group Limited Indole derivative
EP0490689A1 (en) * 1990-12-12 1992-06-17 Glaxo Group Limited 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide sulphate (2:1)
EP0503440A1 (en) * 1991-03-08 1992-09-16 Glaxo Group Limited Compositions containing sumatriptan
US6255502B1 (en) * 1996-07-11 2001-07-03 Farmarc Nederland B.V. Pharmaceutical composition containing acid addition salt of basic drug
US20030181432A1 (en) * 2000-06-29 2003-09-25 Lancaster Robert William Process for preparing and harvesting crystalline particles
WO2003105836A1 (en) * 2002-06-13 2003-12-24 Dr. Reddy's Laboratories Limited 3-'2-(Dimethylamino) ethyl!-N-methyl-1H-indole-5-methanesulfonamide and the Succinate Thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009037718A2 (en) * 2007-09-17 2009-03-26 Matrix Laboratories Limited Process for preparing 3-(2-(dimethylamino)ethyl)-n- methyl-1h-indole-5-methanesulfonamide and product thereof
WO2009037718A3 (en) * 2007-09-17 2010-01-21 Matrix Laboratories Limited Process for preparing 3-(2-(dimethylamino)ethyl)-n- methyl-1h-indole-5-methanesulfonamide and product thereof
WO2009128089A2 (en) * 2008-02-11 2009-10-22 Matrix Laboratories Limited Novel solvate form of sumatriptan succinate and process for preparing sumatriptan salt employing the same
WO2009128089A3 (en) * 2008-02-11 2010-03-11 Matrix Laboratories Limited Novel solvate form of sumatriptan succinate and process for preparing sumatriptan salt employing the same

Similar Documents

Publication Publication Date Title
US6242460B1 (en) Zolpidem salt forms
US6559293B1 (en) Topiramate sodium trihydrate
US20040024031A1 (en) Solvates and polymorphs of ritonavir and methods of making and using the same
US20070026078A1 (en) Pharmaceutical co-crystal compositions
US20070059356A1 (en) Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
US20070021510A1 (en) Modafinil compositions
US20040019211A1 (en) Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
WO2006007448A2 (en) Pharmaceutical co-crystal compositions and related methods of use
US6369094B1 (en) Polymorphic salt
WO2005023198A2 (en) Modafinil compositions
US20050070551A1 (en) Novel crystalline forms of conazoles and methods of making and using the same
WO2005089511A2 (en) Novel pharmaceutical forms, and methods of making and using the same
US20040063782A1 (en) Bicalutamide forms
US20090018202A1 (en) Modafinil compositions
WO2004089313A2 (en) Novel olanzapine forms and related methods of treatment
US20060100432A1 (en) Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
WO2005077894A1 (en) Modafinil compositions
CN1575287A (zh) 乙酰替苯胺衍生物的α型或β型结晶
US6391906B2 (en) Crystals of celecoxib
CN1970547A (zh) 非布司他的新晶型及其制备方法
US20090202647A1 (en) Solid form of racemic rotigotine
WO2006048296A1 (en) Organic compounds
US6664267B1 (en) Crystalline fluoroquinolone arginine salt form
US20020193386A1 (en) Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof
JP2007524596A (ja) 共結晶医薬組成物

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct app. not ent. europ. phase